Question 1

How many shares of TEVA does GLENVIEW CAPITAL MANAGEMENT, LLC own?

Accepted Answer

As of 2026-Q2, GLENVIEW CAPITAL MANAGEMENT, LLC holds 5.1M shares of TEVA (TEVA PHARMACEUTICAL-SP ADR).

Question 2

What is GLENVIEW CAPITAL MANAGEMENT, LLC's TEVA position worth?

Accepted Answer

As of 2026-Q2, GLENVIEW CAPITAL MANAGEMENT, LLC's TEVA position is worth $172.1M.

Question 3

Is GLENVIEW CAPITAL MANAGEMENT, LLC buying or selling TEVA?

Accepted Answer

In 2026-Q2, GLENVIEW CAPITAL MANAGEMENT, LLC decreased their TEVA position (-23.7% change in shares).

Question 4

When did GLENVIEW CAPITAL MANAGEMENT, LLC first buy TEVA?

Accepted Answer

Based on available 13F filings, GLENVIEW CAPITAL MANAGEMENT, LLC first reported a position in TEVA in 2024-Q3. They have held the position across 11 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	5.1M	-23.7%	$172.1M	3.1%	$33.88	0
2026-Q1	Decreased	6.7M	-60.2%	$200.6M	5.0%	$32.28	0
2025-Q4	Increased	16.7M	+0.2%	$521.8M	10.6%	$31.34	61
2025-Q3	Increased	16.7M	+5.5%	$337.2M	7.5%	$19.18	64
2025-Q2	Increased	15.8M	+7.1%	$265.2M	7.4%	$16.76	65
2025-Q1	Increased	14.8M	+74.8%	$227.1M	5.6%	$15.08	91
2024-Q4	Unchanged	8.5M	0.0%	$186.4M	4.7%	$22.32	0
2024-Q3	Decreased	8.5M	-7.7%	$152.4M	2.9%	$17.46	0